Carboplatin – A 2nd line chemotherapy?

Carboplatin is a chemotherapy agent used for treatment of many types of cancer. Currently, it is approved by the Food & Drug Administration (FDA) for treating patients with ovarian and non-small cell lung cancer. However, some oncologists use carboplatin “off-label” for other cancers. Commonly, these “off-label” uses include testicular, stomach, and bladder cancers as well [...]

Life Does Not Come with Do-Overs

Whether you are struggling with advanced prostate cancer, or a member of your family is, we all know how this journey can be very difficult. As we look forward to this New Year, 2011, we can be sure that there will be many difficult and down periods, but we should also remember there will also [...]

Learning from the Regrets of the Dying

Bronnie writes a blog, Inspiration and Chai, Warmth for the soul and body.  A recent post on her blog deals with what she has learned about some of the regrets of the dying.  I have received permission from her to re-post this on the advanced prostate cancer blog. We all know that having advanced prostate [...]

Testimony of James L. Mohler, MD Before the Senate Committee on Foreign Relations The Al-Megrahi Release: One Year Later

Expert opinion about the “three months to live” prognosis Scottish physicians gave Abdelbaset Ali Mohmed al-Megrahi in August 2009. September 29, 2010 “Based on the medical report issued by the Scottish authorities, I believe that three-month prognosis was medically unjustifiable. Any physician with any training or experience in treating prostate cancer would have known that [...]

Prostate Cancer SATURN Trial, a Phase 3 Trial in Men with Metastatic Prostate Cancer

A new phase 3, registration trial has been announced by OncoGenex Pharmaceuticals, Inc. of its investigational drug custirsen sodium (OGX-011/TV-1011). The trial, for men with metastatic castrate resistant prostate cancer (mCRPC) is referred to as the Prostate Cancer SATURN Trial. This randomized, controlled, trial will include approximately 50 cancer centers and is planned to enroll [...]

Prostate Cancer Deaths Predicted to Rise By 17 Percent in 2010 !

Did you hear the news? These alarming 2010 projections for prostate cancer deaths were just released. Isn't it nice that they were released just prior to Father’s Day, so have a happy Father’s Day. These projections call for a massive 17 % increase in prostate cancer caused deaths as well as a more than 13 [...]

Time Between Treatment And PSA Recurrence Predicts Death From Prostate Cancer

According to a study last year at Fox Chase Cancer Center, men whose prostate specific antigen (PSA) rise within 18 months of having primary radiotherapy are more likely to develop advanced prostate cancer and die of their disease. […]

Cancer and Organ Donation – A Surprise Answer

Don Greggs, a long time prostate cancer survivor, recently asked his niece if people with cancer are able to donate organs at the time of their death. His niece who has worked in the organ recovery field gave him an answer that surprised me. She said that having cancer does not eliminate the possibility of [...]

Death Due to Competing Risks in Men with Metastatic Prostate Cancer

The old adage, prostate cancer is the cancer that you die with not the cancer you die from has been around for a long time. No question compared too many other cancers prostate cancer does progress more slowly than many other cancers. But, is this adage true? Men with prostate cancer have competing mortality risks [...]